- Home
- SVM vs CGEM Comparison
SVM vs CGEM Comparison
Compare SVM & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVM
- CGEM
- Stock Information
- Founded
- SVM N/A
- CGEM 2016
- Country
- SVM Canada
- CGEM United States
- Employees
- SVM N/A
- CGEM N/A
- Industry
- SVM Precious Metals
- CGEM Biotechnology: Pharmaceutical Preparations
- Sector
- SVM Basic Materials
- CGEM Health Care
- Exchange
- SVM Nasdaq
- CGEM Nasdaq
- Market Cap
- SVM 1.1B
- CGEM 482.7M
- IPO Year
- SVM N/A
- CGEM 2021
- Fundamental
- Price
- SVM $5.15
- CGEM $6.29
- Analyst Decision
- SVM Strong Buy
- CGEM Strong Buy
- Analyst Count
- SVM 1
- CGEM 8
- Target Price
- SVM $6.75
- CGEM $27.25
- AVG Volume (30 Days)
- SVM 5.3M
- CGEM 550.4K
- Earning Date
- SVM 11-06-2025
- CGEM 11-06-2025
- Dividend Yield
- SVM 0.48%
- CGEM N/A
- EPS Growth
- SVM N/A
- CGEM N/A
- EPS
- SVM 0.25
- CGEM N/A
- Revenue
- SVM $308,064,000.00
- CGEM N/A
- Revenue This Year
- SVM $3.27
- CGEM N/A
- Revenue Next Year
- SVM $33.68
- CGEM N/A
- P/E Ratio
- SVM $20.63
- CGEM N/A
- Revenue Growth
- SVM 35.50
- CGEM N/A
- 52 Week Low
- SVM $2.87
- CGEM $6.24
- 52 Week High
- SVM $5.47
- CGEM $18.62
- Technical
- Relative Strength Index (RSI)
- SVM 59.34
- CGEM 33.86
- Support Level
- SVM $4.81
- CGEM $6.44
- Resistance Level
- SVM $5.47
- CGEM $6.76
- Average True Range (ATR)
- SVM 0.23
- CGEM 0.41
- MACD
- SVM 0.04
- CGEM -0.10
- Stochastic Oscillator
- SVM 66.49
- CGEM 2.83
About SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is a mineral exploration company, engaged in the acquisition, exploration, development, and mining of mineral properties. The company's producing mines are located in China, and exploration and development projects are located in China and Ecuador. Its project portfolio comprises the El Domo copper-gold and the Condor gold project in Ecuador. In addition, it operates several silver-lead-zinc mines at the Ying Mining District in Henan Province, China, and the GC silver-lead-zinc mine in Guangdong Province, China. A majority of the company's revenue is generated through the sale of silver concentrates. Its reportable operating segments are the Ying Mining District and GC Mine in China, which derive maximum revenue, and the El Domo and Condor projects in Ecuador.
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.